Cathepsin D (CTSD), a lysosomal protease involved in protein degradation in skeletal and heart muscles, was pointed out as potential biomarker for SMA, as upregulated compared to non-SMA subjects. This evidence concerns the gene CTSD and proximal spinal muscular atrophy.